The Ninth Annual Fall Symposium & Luncheon "Hope on the Horizon" comprised a morning symposium with leading Alzheimer's researchers and a luncheon to present the Charles Evans Award. This year we honored David R. Weinreb, Chief Executive Officer of The Howard Hughes Corporation.
The event began with a morning symposium "Biomarkers to Accelerate Drug Development for Alzheimer's Disease," moderated by Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. Panelists include:
- Richard S. Isaacson, MD, Director, Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders Program
- Michelle M. Mielke, PhD, Professor, Departments of Health Sciences Research & Neurology, Mayo Clinic
- Mark A. Mintun, MD, Vice President of Neuroscience, Eli Lilly & Co.
All proceeds from "Hope on the Horizon" support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.